| Literature DB >> 25431646 |
Steven H Liang1, Daniel L Yokell2, Raul N Jackson2, Peter A Rice2, Ronald Callahan1, Keith A Johnson1, David Alagille3, Gilles Tamagnan3, Thomas Lee Collier4, Neil Vasdev1.
Abstract
The synthesis of fluorine-18 labeled 3-fluoro-5-[(pyridin-3-yl)ethynyl] benzonitrile ([18F]FPEB) for imaging metabotropic glutamate receptor subtype type 5 (mGluR5) was achieved with a commercial continuous-flow microfluidics device. This work represents the first positron emission tomography (PET) radiopharmaceutical that is suitable for human use with this technology. We also describe a validated synthesis of [18F]FPEB with a commercial reactor-based system.Entities:
Year: 2014 PMID: 25431646 PMCID: PMC4243709 DOI: 10.1039/C3MD00335C
Source DB: PubMed Journal: Medchemcomm ISSN: 2040-2503 Impact factor: 3.597